Fred Hutch Innovation Lab
Spurring Novel Technology Development and Adoption
In the Fred Hutch Innovation Lab, we are leading the in-house development and early adoption of powerful new research technologies that hold the potential to drive lifesaving discoveries in cancer immunology and other areas of science.
Our Areas of Focus
Unlocking Secrets of Cell Activity
We are introducing technologies for spatial analysis of single-cell transcription profiling, giving scientists unprecedented insights into cells’ inner workings.
Profiling the Immune System
We are increasing the availability of genetic data and analysis that makes information about the immune system more accessible to all scientists.
Driving Technological Innovation
We are discovering, testing and bringing new technologies online, targeting those of greatest utility for scientists at the vanguard of the promising field of immuno-oncology.
Our Facilities and Technology Pipeline
Our lab is one of the hallmarks of Fred Hutch’s Steam Plant building, a historic landmark newly redeveloped into a one-of-a-kind facility dedicated to spurring innovation at the nexus of data science and immunology.
There, we use a three-stage pipeline to develop novel technologies for use by the scientific community. First, we test, compare, advance and tailor new technologies that our Advisory Board has selected for their potential to facilitate the next discoveries in immunotherapy. Then, we work with selected researchers to evaluate the technology as they harness it to advance their early-stage research projects. Finally, we make that technology and the protocols and procedures we’ve developed available to researchers across the Hutch to accelerate their science.
Scientific Director
Dr. Evan Newell
Dr. Newell became the scientific director of the Fred Hutch Innovation Lab (FHIL) in January of 2022. He is an immunologist who develops and employs new technologies for accurately identifying specific biological signatures of human health and disease, including cancer and infectious diseases. He and his team work with blood and tissue samples, using mass cytometry and other single-cell analysis methods to better understand how the specificities of immune T cells influence their roles in clinically-productive responses against pathogens or cancers.
Dr. Phil Bradley
Dr. Lillian Cohn
Dr. Marion Dorer
Dr. Gordon Roble
Dr. Scott Furlan
Dr. Geoffrey Hill
Dr. Stan Riddell
